Baader Bank Aktiengesellschaft’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,289	Closed	-$4.57K	–	504
2024 Q4	$4.57K	Buy	24,289 +9,244	+61%	+$1.83K	﹤0.01%	371
2024 Q3	$2.25K	Buy	+15,045	New	+$4.81K	﹤0.01%	427

Other funds holding RNLX

IIC

Ironwood Investment Counsel Scottsdale, Arizona $762M AUM 23.02% 1-Year Est. Return

Baader Bank Aktiengesellschaft's RNLX Position: Q1 2025 in Review

Baader Bank Aktiengesellschaft sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2025, closing a stake of 24,289 shares — an estimated $4.57K sold.

Baader Bank Aktiengesellschaft first reported a position in RNLX in Q3 2024 and held it in 2 quarters. The position peaked at $4.57K in Q4 2024. 1 fund tracked by Wall St. Rank holds RNLX as of Q1 2025.

Baader Bank Aktiengesellschaft reported no remaining Renalytix plc American Depositary Shares position as of Q1 2025 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 24,289 Renalytix plc American Depositary Shares shares in Q1 2025, an estimated $4.57K.
Baader Bank Aktiengesellschaft first reported a position in Renalytix plc American Depositary Shares in Q3 2024 and held it in 2 quarters.
Baader Bank Aktiengesellschaft's Renalytix plc American Depositary Shares position peaked at $4.57K in Q4 2024.
1 fund tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2025, filed 8 May 2025.